BLDR three-lens brief
Evidence-based stock research on BLDR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 9.7pp over 30 days. · P/E of 168 — priced for high growth; little margin of safety.
- Outperforming SPY by 9.7pp over 30 days.
- P/E of 168 — priced for high growth; little margin of safety.
- Reported earnings on 2026-10-29.
BLDR closed at $62.34 (-0.94%) as of 2026-11-12. Market cap: $6.71B. P/E (trailing) 168.5. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 9.7pp over 30 days.. Concerns: p/E of 168 — priced for high growth; little margin of safety.. Last quarter: Revenue $3.85B, net income $60.41M, free cash flow $140.29M.
Why three lenses on BLDR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLDR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BLDR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLDR brief"></iframe>